All In Biotech

Drug Trial Radar · NCT07502508

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

Phase 2 Randomized, Double-blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Icovamenib in Participants With Type 2 Diabetes Not Achieving Glycemic Targets Despite GLP-1-Based Therapy

Last checked: Nov 20, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

Apr 30, 2026

Primary completion

Jun 2027

Study completion Jul 2027

Sponsor

Lead sponsor
Biomea Fusion Inc.Industry
Sponsor type
Industry
First posted
Mar 31, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a phase 2 randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of icovamenib in participants with Type 2 Diabetes (T2D) not achieving glycemic targets despite GLP-1-based therapy.

Conditions

  • Type 2 Diabetes

Interventions

  • icovamenib 100 mgDrug

    icovamenib 100 mg

  • PlaceboDrug

    Matching placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To demonstrate that icovamenib 100 mg once daily for 12 weeks is superior to placebo for glycemic controlTime frame: 26 weeks

Locations

20 sites in 1 country. Site status is shown where the registry gives one.

  • Central Research Associates, LLC dba Flourish Research

    Birmingham, Alabama · Recruiting

  • Hope Clinical Research

    Canoga Park, California · Recruiting

  • Ark Clinical Research

    Long Beach, California · Recruiting

  • Catalina Research Institute, LLC

    Montclair, California · Recruiting

  • Paradigm Clinical Research Centers, LLC

    San Diego, California · Recruiting

  • Southwest General Healthcare Center

    Fort Myers, Florida · Recruiting

  • Panax Clinical Research

    Miami Lakes, Florida · Recruiting

  • Flourish Research Orlando

    Winter Park, Florida · Recruiting

  • Centricity Research, Endocrine Consultants PC

    Columbus, Georgia · Recruiting

  • David Kavtaradze MD, Inc

    Cordele, Georgia · Recruiting

  • Excel Clinical Research

    Las Vegas, Nevada · Recruiting

  • Centricity Research, Lucas Research, Inc.

    Morehead City, North Carolina · Recruiting

  • Diabetes and Endocrinology Associates of Stark County

    Canton, Ohio · Recruiting

  • Elligo Health Research, Inc.

    Austin, Texas · Recruiting

  • Zenos Clinical Research

    Dallas, Texas · Recruiting

  • Synergy Group Medical

    Houston, Texas · Recruiting

  • Epic Clinical Research

    Lewisville, Texas · Recruiting

  • Synergy Group Medical

    Missouri City, Texas · Recruiting

  • Diabetes & Glandular Disease Clinic, P.A.

    San Antonio, Texas · Recruiting

  • Burke Internal Medicine and Research

    Burke, Virginia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.